ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.19
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.365
0.37%
Bitcoin
57,334.96
-0.73%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
06/23/20235:34AMDow Jones NewsTrending: GSK Agrees Confidential Settlement Over Zantac LitigationNYSE:GSKGSK plc
06/23/20232:46AMDow Jones NewsGSK Reaches Confidential Settlement Over Zantac LitigationNYSE:GSKGSK plc
06/22/20233:21AMDow Jones NewsGSK Says RSV Vaccine Arexvy Recommended by US Health AuthoritiesNYSE:GSKGSK plc
06/21/20238:26PMBusiness WireUS Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision makingNYSE:GSKGSK plc
06/21/20238:00AMBusiness WireGSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasonsNYSE:GSKGSK plc
06/21/20237:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/21/20232:48AMDow Jones NewsGSK's RSV Vaccine Phase 3 Trial Showed Positive DataNYSE:GSKGSK plc
06/20/20238:00AMBusiness WireGSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis BNYSE:GSKGSK plc
06/16/20232:46AMDow Jones NewsGSK Gets Extension to FDA Review Period for Momelotinib TreatmentNYSE:GSKGSK plc
06/07/20232:45PMDow Jones NewsTrending: GSK Vaccine For RSV Gets Authorization in EuropeNYSE:GSKGSK plc
06/07/20236:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/07/20232:54AMDow Jones NewsGSK Receives Authorization for RSV Vaccine From European CommissionNYSE:GSKGSK plc
06/06/20236:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/06/20232:44AMDow Jones NewsGSK Gets FDA File Acceptance For Jemperli Endometrial Cancer TreatmentNYSE:GSKGSK plc
06/01/202311:56AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/01/20238:00AMBusiness WireGSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the USNYSE:GSKGSK plc
05/30/20232:33PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:GSKGSK plc
05/16/20235:01PMBusiness WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNYSE:GSKGSK plc
05/16/20235:01PMBusiness WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNYSE:GSKGSK plc
05/15/202312:53PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/15/202312:49PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/202311:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/20236:50AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/20236:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/20236:39AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/20236:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/12/20233:24AMDow Jones NewsGSK Welcomes Canadian Court Decision to Dismiss Proposed Zantac LawsuitNYSE:GSKGSK plc
05/12/20232:47AMDow Jones NewsGSK Sells Haleon Shares at 335p Each, Raising GBP804 MillionNYSE:GSKGSK plc
05/11/202312:25PMDow Jones NewsGSK to Sell Its 2.5% Stake in HaleonNYSE:GSKGSK plc
05/11/202312:14PMGlobeNewswire Inc.SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 CongressNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
AMEX
SPY
SPDR S&P 500
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
USOTC
BIEL
Bioelectronics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved